Search results
Dow Jones Futures: Nvidia's New Buy Point; GameStop Extends 74% 'Roaring Kitty' Surge
Investor's Business Daily· 12 hours agoNetApp, NXP Semiconductors, Taiwan Semiconductor Manufacturingand Tradeweb Markets — plus Dow Jones...
Merck's endometrial cancer therapy fails trial
Reuters via Yahoo News· 5 days agoThe drugmaker's Keytruda therapy in combination with chemotherapy was being evaluated in about 1,095 patients with high-risk endometrial cancer after...
Dow Jones Rises To Extend Win Streak; Nvidia Stock Reverses Lower Despite Buy Rating
Investor's Business Daily· 22 hours agoChipotle and Merck featured in this Stocks Near A Buy Zone column. An essential resource for daily...
Merck treatment for a type of uterus cancer fails trial
KFGO· 5 days ago(Reuters) - Merck said on Thursday its treatment for a type of uterus cancer did not meet the main...
Drugmakers in Medicare negotiations spent more on shareholder payments and marketing than R&D last...
The Hill· 6 days agoThe report looked at eight companies — Johnson & Johnson, Amgen, AstraZeneca, Bristol Myers Squibb,...
Merck to Participate in the Bank of America Securities 2024 Healthcare Conference
Morningstar· 6 days agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Caroline Litchfield, executive vice president and chief financial officer, is ...
Data-Based Insights About Merck & Co Inc
Stocks Register· 5 days agoMerck & Co Inc (NYSE:MRK) price on Thursday, May 09, rose 0.08% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $129.66. A look ...
17. Transcarent
CNBC· 2 hours agoIn a paradigm shift accelerated by the pandemic, changes are coming swiftly to a broken health system, and digital health-care has taken off with...
A Look at Pharma ETFs Post Q1 Earnings
Zacks via Yahoo Finance· 7 days agoThe U.S. drug giant reaffirmed its revenue guidance of $58.5-$61.5 billion and raised its adjusted earnings per share to $2.15-$2.35 from $2.05-$2.25 for...
Lula’s progress plan for Brazil: A year on
Pharmaceutical Technology via Yahoo Finance· 1 day ago“Brazil has its particularities, like any other country, but we have a dynamic healthcare system, which is a global reference in several areas and of...
